Purpose of the Test
- To identify patients eligible for ALK inhibitor therapies.
- To customize the treatment plan based on genetic markers.
- To provide prognostic information regarding the tumor behavior.
Book ALK Gene Testing in Saudi Arabia | Lahalak Medical Platform
Identify the most effective targeted therapy for lung cancer by testing for ALK gene rearrangements. This specialized genetic test helps oncologists select the best treatment plan tailored to your specific biological profile.
Scientific name: ALK Gene Rearrangement Testing
A precise genetic test performed on lung tissue samples to detect ALK gene rearrangements, helping determine if a patient is eligible for targeted ALK inhibitor therapies for improved outcomes.
Service type
Oncology Genetic Testing
Duration
7-10 working days
Fasting
Fasting is not required
Included Services
- Tissue sample analysis
- Detailed genetic report
- Targeted therapy recommendations
Medical Service Information
Target Groups
- Patients diagnosed with Non-Small Cell Lung Cancer (NSCLC).
- Patients seeking personalized targeted therapy options.
- Individuals with advanced-stage lung cancer requiring molecular profiling.
Understanding Your Results
- Positive Result: Indicates ALK gene rearrangement is present; targeted therapy is likely effective.
- Negative Result: No rearrangement detected; alternative treatment protocols will be considered.
Conditions & Notices
- Tumor tissue biopsy sample is required
- Previous medical reports are recommended
Medical services you might also like
